GITNUX MARKETDATA
Browse Our Category
Medical Conditions Disorders
Latest update:
Cte Statistics
CTE statistics reveal a pattern that starts with mood and behavior and often ends in severe brain damage, with cognitive impairment in 85% of people at stage 3 or higher and Alzheimer like changes split off by tau tests such as 90% specific p tau217. You will see why no validated antemortem test exists yet, how repeated sub concussive hits can drive risk 3.5 times in soccer, and what the newest biomarker and imaging signals mean for earlier recognition.
Hiv Global Statistics
With 39.0 million people living with HIV worldwide and 29.8 million already on antiretroviral therapy, the picture is both improving and incomplete. From a 69% drop in AIDS deaths since the 2004 peak to the fact that only 72% of people on ART reached viral suppression in 2022, this Hiv Global page connects what prevention and treatment achieved with what still leaves millions behind.
Long Covid Statistics
Long COVID is not a vague aftereffect it can raise cardiovascular complications by 2.5 times and push dementia risk 63% higher while even mortality can be 2 times higher than controls. This statistics page pulls together the newest risk signals and symptom rates, from pulmonary fibrosis in severe ME/CFS like cases to dysautonomia and work disability, and shows what seems to lower risk such as vaccination and early treatment.
Non Hodgkin Lymphoma Statistics
Non Hodgkin lymphoma is diagnosed in about 80,550 people in the United States in 2023, and the page connects the early clues clinicians chase like painless lymph node swelling in 70 to 80% of patients with the staging and testing metrics that can change outcomes, from PET CT sensitivity of 90 to 95% for FDG avid disease to 5 year overall survival climbing to 74% overall. You will see why aggressive forms often hinge on details such as LDH elevation in 40 to 50%, Ki 67 over 40% in 60%, and the survival gap between low risk and high risk groups based on IPI scoring, plus the biomarkers and biopsy techniques that confirm subtype when treatment decisions depend on precision.
Children Cancer Statistics
About 400,000 children and adolescents worldwide are diagnosed with cancer every year, yet survival can swing dramatically depending on where care is delivered and what subtype it is. This page puts the latest picture side by side, including 2022 US diagnoses at 15,780 and stark outcome gaps tied to access to treatment, so you can see both the scale and the urgency behind childhood cancer.
Stage 4 Lung Cancer Survival Statistics
Stage 4 lung cancer survival is improving but still swings dramatically by tumor biology and treatment, from targeted wins like MARIPOSA 2’s amivantamab plus chemo PFS of 6.3 months and EVOKE 01 sacituzumab govitecan median OS of 10.7 months to the stark reality that distant disease carries a median OS of about 11.1 months for stage IV NSCLC and only around 6.3% 5 year survival. This page connects the latest trial signals and context specific outcomes across NSCLC and SCLC so you can see exactly why an EGFR, ALK, or KRAS G12C result can change the odds far more than stage labels alone.
Diabetic Foot Amputations Statistics
Diabetic foot amputations carry a high price fast with 30 day mortality of 10 to 15% and wound healing failure in 40% of cases after amputation. Even after healing, the struggle continues with 45 to 50% 5 year mortality, 40% reulceration within 1 year, and a 90 day readmission rate of 40% in diabetics, plus major functional loss for 70% of survivors.
Bicornuate Uterus Statistics
Bicornuate uterus affects about 0.4 to 1% of women and is often missed until imaging clarifies what a routine pelvic exam can only suggest, yet diagnosis is remarkably precise with 3D ultrasound specificity reaching 99 to 100%. The page links what matters most for outcomes, including renal anomalies in 20 to 40% of cases and a 65% singleton live birth chance without treatment that can climb to 85% after metroplasty, while also addressing the surprising cancer risk signal and how likely multiples are to survive.
Childhood Leukemia Statistics
From bone pain in 25 to 40 percent of childhood ALL, to marrow and blood clues that flag urgent risk like hyperleukocytosis over 100,000 per μL and thrombocytopenia in 70 to 80 percent, this page puts diagnosis patterns and modern outcome markers side by side. It also tracks how today’s testing and monitoring, including MRD by day 15 predicting excellent outcomes, help explain why many children now reach survival rates around 91 percent in the 2010s compared with 60 percent in the 1990s.
Rare Disease Statistics
After an average diagnostic odyssey of 5 to 7 years and up to 40 percent misdiagnosis, Whole exome sequencing can solve 30 to 40 percent of rare undiagnosed cases, yet only about 20 percent of rare diseases have specific clinical tests. This 2025 style statistics page tracks where delays come from, how tools like AI phenotyping and telemedicine can cut accuracy and time gaps by around 30 percent and 20 percent, and why registry matching, imaging, and gene confirmation still leave many patients without answers.
Rsd Statistics
RSD affects about 99% of people with ADHD and is often missed in routine assessments where emotional screening is lacking, yet it can drive intense rejection pain that lasts 1 to 3 hours and shows up with a staggering 15-year average delay to recognition. See how RSD clusters with anxiety, depression, autism, insomnia, and even panic episodes, plus what newer screening and feedback methods reveal to shorten misdiagnosis and move treatment from mood guesses to rejection sensitive dysphoria itself.
Autism Spectrum Statistics
Autism Spectrum statistics reveal sharp, practical gaps, from a 2.8 percent US prevalence in 2023 to 64 percent of autistic adults having no paid job, alongside health and safety burdens like suicide attempts at 3 times the rate and a 16 to 36 year reduction in life expectancy for those with intellectual disability. You will also find how comorbidities and daily realities intersect, such as anxiety disorders in 42 percent and sleep problems affecting 69 percent, plus how late language and sensory differences can be detected early.
Myeloma Statistics
When myeloma announces itself, it is often not subtle since 85% of patients present with CRAB features and up to 80% report bone lesions or fatigue, yet the first symptom is frequently back pain in 60%. This page pulls together the most clinically useful contrast between early warning patterns and outcomes, from renal impairment in 48% of newly diagnosed patients to modern MRD detection and survival differences by risk markers.
Colon Cancer Age Statistics
Age changes everything, from a 5 year relative survival of 65% for colon cancer diagnosed under 50 to 90% for ages 65 to 74, and then down to 14% once distant metastatic disease appears for ages 50 to 64. This page connects those shifts to stage and global age patterns, plus screening guidance starting at 45 for average risk, so you can see where risk rises and why catching it earlier matters.
Hemorrhoids Statistics
Even though most people manage hemorrhoids conservatively, sharp risk markers still stand out in current evidence such as chronic bleeding causing anemia in 3 to 6 percent of untreated patients, and grade IV strangulation leading to ulceration in 15 percent. You will also see why 90 percent of cases remain stable or improve long term, while outcomes vary by treatment with rubber band ligation recurrence of 10 to 15 percent at 5 years and temporary post hemorrhoidectomy incontinence affecting 5 to 10 percent.
Melanoma Cancer Statistics
See how a “maybe” lesion can flip to “high risk” fast using skin signs and modern imaging, where dermoscopy reaches 90% accuracy versus 71% by naked eye and evolving lesions lead to biopsy 90% of the time. Then connect those clinic signals to outcomes and prevention with the stark facts that melanoma incidence rises 1.1% per year in the US from 2012 to 2021 and 2023 still brought 97,610 new invasive cases, even as survival improves when the right tests and treatments hit early.
Als Statistics
AI private investment surged to $93.5 billion in 2023, while forecasts project AI could add $15.7 trillion to the global economy by 2030 and automate a huge share of work hours in the US, making the upside impossible to ignore. But the page also confronts the friction behind the hype, from bias and ethics failures to regulation and energy costs, so you can see what is actually accelerating and what is slowing adoption.
Leprosy Statistics
2022 brought 175,786 new leprosy detections worldwide, a 3% drop from 2021, yet the page reveals why the disease still spreads through everyday household contact and nasal exposure, and how reactions and nerve damage shape outcomes. You will see the striking immunity split between tuberculoid and lepromatous leprosy, from thickened ulnar nerves and claw hand to the 10 to 20% risk of corneal ulcers, alongside the reaction rates that most often trigger sudden disability.
Adhd Race Statistics
New CDC reporting keeps ADHD disparities in sharp focus, with ever diagnosed rates of 9.8% for White youth versus 6.3% for Hispanic youth. ADHD Race tracks how diagnosis and treatment diverge across race and region, from school underrecognition to referral and medication gaps, including Black children facing lower referral odds and adults showing doubled underdiagnosis.
Secondary Infertility Statistics
Secondary infertility has a way of stacking causes, and the most common culprits are not just one problem but a chain, from tubal factor at 35% and endometriosis recurrence at 40% to male factor at 25%. Updated outcomes matter too, because CDC 2022 data shows live birth after secondary IVF ranges from 42% under 35 down to 12% at 38 to 40, with a large share of couples also conceiving spontaneously within 2 years.